NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for ISTA Pharmaceuticals


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


 Refine Search
Display Mode: Context | Summary
Coldpack(TM) to Preview New Pharmaceutical Pouch at PACK EXPO
2009 OCT 20 ... Organization for Standardization (ISO) and the International Safe Transit Association (ISTA). Originally founded in 2000, Coldpack's United States operations are now located in a ... Of Energy, Ecology, Environment, Oil & Gas, Technology, Biotechnology, Patents Actions, Pharmaceuticals, Vaccines, Coldpack. This article was prepared by Drug Law Weekly editors ...
Subject: Coldpack
Price: $3.00
*
Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
2009 JUL 13 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) announced the Dermatologic and Ophthalmic Drugs Advisory Committee ...
Subject: Allergies
Price: $3.00
*
Examine the Ophthalmic Pharmaceuticals Market
2009 MAR 16 ... GSK InSite Vision Inspire ISTA Pharmaceuticals Kowa Kyowa Hakko Kirin Laborotorios Sophia ...
Subject: ReportLinker
Price: $3.00
*
ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
2009 JUN 15 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced it has received notification from the U.S. Food and Drug ...
Subject: Allergies
Price: $3.00
*
ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
2009 SEP 7 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced positive preliminary Phase 3 results from the Company's ...
Subject: Surgery
Price: $3.00
*
ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
2009 JUN 22 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced positive results from a proof-of-concept Phase 2 clinical ...
Subject: Eye Disease
Price: $3.00
*
ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
2009 SEP 21 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced preliminary results from two recently completed studies ...
Subject: Antimicrobials
Price: $3.00
*
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
2009 NOV 23 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced additional results from the Company's Bepreve™ ...
Subject: Allergies
Price: $3.00
*
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting
2009 NOV 2 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) announced poster presentations of results from the Company's ...
Subject: Pharmaceuticals
Price: $3.00
*
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting
2009 MAY 18 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), today presented results from the Company's Bepreve(TM) ...
Subject: Allergies
Price: $3.00
*
ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
2009 MAR 3 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), reported financial results for the quarter and the year ended ...
Subject: ISTA Pharmaceuticals, Inc.
Price: $3.00
*
ISTA Pharmaceuticals Reports Second Quarter 2009 Financial Results and Raises Full Year Revenue Guidance
2009 AUG 17 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), reported financial results for the three months ended June 30, ...
Subject: Pharmaceuticals
Price: $3.00
*
ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
2009 NOV 16 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), reported financial results for the three months ended September 30, ...
Subject: Pharmaceuticals
Price: $3.00
*
ISTA Pharmaceuticals to Present at 2009 BIOCOM Investor Conference
2009 NOV 3 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced it will present at the 2009 BIOCOM Investor Conference at ...
Subject: Pharmaceuticals
Price: $3.00
*
ISTA Pharmaceuticals to Present at NewsMakers in the Biotech Industry Conference
2009 SEP 22 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced it will present at the NewsMakers in the Biotech Industry ...
Subject: Pharmaceuticals
Price: $3.00
*
ISTA Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
2009 MAR 24 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced it will present at the Cowen and Company 29th Annual ...
Subject: Pharmaceuticals
Price: $3.00
*
ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
2009 SEP 21 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) announced the U.S. Food and Drug Administration (FDA) has approved ...
Subject: Allergies
Price: $3.00
*
ISTA Pharmaceuticals, Inc.: Strategic Analysis Review of One of the Leading Manufacturers of Opthalmis Products
2009 APR 20 ... has announced the addition of Global Markets Direct's new companyprofile "ISTA Pharmaceuticals, Inc. - Strategic Analysis Review" to their offering. ...
Subject: Research and Markets
Price: $3.00
*
ISTA Pharmaceuticals' First Quarter 2009 Revenue Increases 32% to $20.4 Million
2009 MAY 19 ... ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA): reported financial results for the three months ended March 31, ...
Subject: Pharmaceuticals
Price: $3.00
*
Research from N.A. Sher et al has provided new information about photophobia
2009 MAR 30 ... 0.4% four times daily (Acular LS, Allergan) or bromfenac 0.09% twice daily (Xibrom, ISTA Pharmaceuticals) in an open label trial." "Patients having both eyes treated ...
Subject: Photophobia
Price: $3.00
*

Results 1 - 20      Next >

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login